natgillin/translations-raw huggingface dataset:
The tablets are packaged in blisters in cardboard boxes containing 20, 30, 60 or 90 tablets, and in HDPE bottles with child resistant closure in cardboard boxes containing 90 tablets.
Tablete su pakirane u blistere u kartonskim kutijama, koje sadrže 20, 30, 60 ili 90 tableta i u HDPE bočice sa zatvaračem koji djeca ne mogu otvoriti, u kartonskim kutijama koje sadrže 90 tableta.
The tablets are packaged in HDPE bottles, each bottle containing 30 tablets with a cotton coiler and desiccant canister.
Tablete su pakirane u boce od polietilena visoke gustoće, a svaka boca sadrži 30 tableta s pamučnom zaštitom i spremnikom sredstva za konzerviranje.
The tablets are packed bottles of 30 tablets or 90 tablets, and each bottle is presented in an outer cardboard box.
Tablete su pakovane u boce s 30 ili 90 tableta, a svaka boca je opremljena vanjskom kartonskom kutijom.
The tablets are packed in high density polyethylene bottles with a child resistant polypropylene closure and a foil induction seal, or in child resistant aluminium blister.
Tablete su pakirane u bocama od polietilena visoke gustoće s polipropilenskim sigurnosnim zatvaračem za djecu i zaštitnom folijom na grlu bočice ili u aluminijskom blister pakiranju sigurnom za djecu.
The tablets are pale brown-yellow, round, biconvex with bevelled edges and possible darker spots.
Tablete su blijedo smeđežute, okrugle, bikonveksne s ukošenim rubovima i mogućim tamnijim točkicama.
The tablets are pink, marbled, round, biconvex with bevelled edges and possible darker spots.
Tablete su ružičaste, mramorirane, okrugle, bikonveksne s ukošenim rubovima i mogućim tamnijim točkicama.
The tablets are provided in a plastic bottle with a child-resistant closure.
Tablete su dostupne u plastičnim bočicama sa sigurnosnim zatvaračem za djecu.
The tablets are provided in blister packs containing 2, 4, 8, or 12 tablets.
Tablete se nalaze u blister pakovanjima koja sadrže 2, 4, 8, ili 12 tableta.
The tablets are provided in blister packs containing 4, 8, or 12 tablets.
Tablete se nalaze u blister pakiranjima koja sadrže 4, 8, ili 12 tableta.
The tablets are provided in blister packs containing 90 tablets and in blister packs containing 300 tablets.
Tablete se isporučuju u blister pakiranjima koja sadrže 90 tableta i u blister pakiranjima koja sadrže 300 tableta.
The tablets are provided in carton boxes with blisters containing 10,30 or 90 tablets.
Tablete su dostupne u kutijama s blisterima koji sadrže 10, 30 ili 90 tableta.
The tablets are provided in UPVC/Monochlorotrifluorethylene blister packs containing 28 tablets.
Tablete su pakirane u UPVC/monoklorotrifluoroetilen blister pakiranjima koja sadrže 28 tableta.
The tablets are round (diameter 8 mm), convex and pink.
Tablete su okrugle (promjera 8 mm), ispupčene i ružičaste boje.
The tablets are supplied in aluminium blister packs of 10, 20, 30, 60, 90, 120 or 180 film-coated tablets.
Tablete se isporučuju u aluminijskim blisterima od 10, 20, 30, 60, 90, 120 ili 180 filmom obloženih tableta
The tablets are supplied in aluminium blister packs of 10, 30, 60 or 90 film-coated tablets.
Tablete se isporučuju u aluminijskim blisterima od 10, 30, 60, ili 90 filmom obloženih tableta.
The tablets are supplied in aluminium/aluminium blister packs containing either 14, 28, 30, 50, 90 or
Tablete se isporučuju u aluminij/aluminij blister pakiranjima koja sadrže 14, 28, 30, 50, 90 ili
The tablets are supplied in aluminium/aluminium blister packs of 14, 28, 30, 50, 56, 60, 90, 98 or 180 tablets.
Tablete se isporučuju u aluminij/aluminij blister pakiranjima od 14, 28, 30, 50, 56, 60, 90, 98 ili 180 tableta.
The tablets are supplied in Aluminium/aluminium blister packs of 14, 28, 30, 50, 56, 84, 90, 98,
Tablete se isporučuju u aluminij/aluminij blisterima sa 14, 28, 30, 50, 56, 84, 90, 98, 112 ili
The tablets are supplied in Aluminium/aluminium blister packs of 14, 28, 30, 50, 56, 84, 90, 98, 112 or 196 tablets or 50 x 1 tablets in Aluminium/aluminium perforated unit dose blisters.
Tablete se isporučuju u aluminij/aluminij blisterima sa 14, 28, 30, 50, 56, 84, 90, 98, 112 ili 196 tableta ili 50 x 1 tableta u aluminij/aluminij blisterima djeljivima na jedinične doze.
The tablets are supplied in blister packs of 14, 28, 30, 50, 56, 84, 90, 98, 112 or 196 tablets.
Tablete se isporučuju u blisterima sa 14, 28, 30, 50, 56, 84, 90, 98, 112 ili 196 tableta.
The tablets are supplied in blister packs of 30 and 100 tablets.
Tablete su dostupne u blister pakovanjima s 30 ili 100 tableta.
The tablets are supplied in PVC/PVDC/Aluminium blister packs of 14, 20, 28 or 56 tablets.
Tablete se isporučuju u PVC/PVDC/aluminij blister pakiranjima od 14, 20, 28 ili 56 tableta.
The tablets are taken twice a day on days 1 to 5 and days 8 to 12 of each treatment cycle.
Tablete se uzimaju dvaput na dan od 1. do 5. dana i od 8. do 12. dana u svakom ciklusu liječenja.
The tablets are to be taken with food (see section 5.2).
Tablete treba uzeti s hranom (vidjeti dio 5.2).
The tablets are to be taken with food (see section 5.2).
Tablete treba uzeti s hranom (vidjeti dio 5.2.).
The tablets are used in children aged 6 years and above and weighing 25 kg or more.
Tablete se koristi kod djece od šest godina ili starije čija je težina najmanje 25 kg.
The tablets are white to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO’ on one side and ‘30’ on the other side.
Tablete su bijele do gotovo bijele boje, plosnate, okrugle, bez ovojnice sa zaobljenim rubovima i utisnutom oznakom ‘PIO’ s jedne strane i ‘30’ s druge strane.
The tablets are white to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO’ on one side and ‘45’ on the other side.
Tablete su bijele do gotovo bijele boje, plosnate, okrugle, bez ovojnice sa zaobljenim rubovima i utisnutom oznakom ‘PIO’ s jedne strane i ‘45’ s druge strane.
The tablets are white to off white, round, biconvex, uncoated tablets debossed with ‘P’ on one side and ‘15’ on other side.
Tablete su bijele do gotovo bijele, okrugle, bikonveksne, bez ovojnice s utisnutom oznakom ‘P’ s jedne strane i ‘15’ s druge strane.
The tablets are white to off-white, oblong, film-coated, embossed ‘15 / 850’ on one face and ‘4833M’ on the other.
Tablete su bijele do gotovo bijele boje, ovalne, filmom obložene s utisnutim „15 / 850“ na jednoj strani i „4833M“ na drugoj.
The tablets are white to off-white, round, convex and debossed with the number ‘15’ on one side and ‘TEVA’ on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘15’ s jedne strane i ‘TEVA’ s druge strane.
The tablets are white to off-white, round, convex and debossed with the number ‘30’ on one side and ‘TEVA’ on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘30’ s jedne strane i ‘TEVA’ s druge strane.
The tablets are white to off-white, round, convex and debossed with the number ‘45’ on one side and ‘TEVA’ on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘45’ s jedne strane i ‘TEVA’ s druge strane.
The tablets are white to off-white, round, convex and marked ‘15’ on one face and ‘ACTOS’ on the other face.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘15’ s jedne strane i ‘ACTOS’ s druge strane.
The tablets are white to off-white, round, convex and marked ‘15’ on one face, ‘AD4’ on the other.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘15’ s jedne strane i ‘AD4’ s druge strane.
The tablets are white to off-white, round, flat and marked ‘30’ on one face and ‘ACTOS’ on the other face.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘30’ s jedne strane i ‘ACTOS’ s druge strane.
The tablets are white to off-white, round, flat and marked ‘30’ on one face, ‘AD4’ on the other.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘30’ s jedne strane i ‘AD4’ s druge strane.
The tablets are white to off-white, round, flat and marked ‘45’ on one face and ‘ACTOS’ on the other face.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘45’ s jedne strane i ‘ACTOS’ s druge strane.
The tablets are white to off-white, round, flat and marked ‘45’ on one face, ‘AD4’ on the other.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘45’ s jedne strane i ‘AD4’ s druge strane.
The tablets are white to off-white, round, flat faced, bevel edged, with inscription ‘I1’ on one side and plain on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate, ukošenih rubova s oznakom „I1” na jednoj strani te bez oznaka na drugoj strani.
The tablets are white to off-white, round, flat faced, bevel edged, with inscription ‘I’ and ‘2’ on either side of the breakline on one side and breakline on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate, ukošenih rubova s oznakama „I” i „2” s dviju strana razdjelne crte na jednoj strani te s razdjelnom crtom na drugoj strani tablete.
The tablets are white to off-white, round, flat faced, bevel edged, with inscription ‘I’ and ‘3’ on either side of the breakline on one side and breakline on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate, ukošenih rubova s oznakama „I” i „3” s dviju strana razdjelne crte na jednoj strani te s razdjelnom crtom na drugoj strani tablete.
The tablets are white to off-white, round, flat faced, bevel edged, with inscription ‘I’ and ‘4’ on either side of the breakline on one side and breakline on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate, ukošenih rubova s oznakama „I” i „4” s dviju strana razdjelne crte na jednoj strani te s razdjelnom crtom na drugoj strani tablete.
The tablets are white to off-white, round, flat faced, bevel edged, with inscription ‘I’ and ‘5’ on either side of the breakline on one side and breakline on other side.
Tablete su bijele do gotovo bijele boje, okrugle, plosnate, ukošenih rubova s oznakama „I” i „5” s dviju strana razdjelne crte na jednoj strani te s razdjelnom crtom na drugoj strani tablete.
The tablets are white, flat, of round shape, scored on both sides, and have a code embossed (one side with the code P11, and one side with the Boehringer Ingelheim company symbol).
Tablete su bijele, plosnate, okruglog oblika, s razdjelnim urezom na obje strane te imaju otisnutu oznaku (s jedne strane oznaku P11, a s druge strane simbol tvrtke Boehringer Ingelheim).
The tablets are white, round, flat, bevelled, 5.5 mm in diameter and engraved with ‘TZ15’ on one side.
Tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 5,5 mm s utisnutom oznakom ‘TZ15’ na jednoj strani.
The tablets are white, round, flat, bevelled, 7 mm in diameter and engraved with ‘TZ30’ on one side.
Tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 7 mm s utisnutom oznakom ‘TZ30’ na jednoj strani.
The tablets are white, round, flat, bevelled, 7 mm in diameter and engraved with ‘TZ30’ on one side.
Tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 7 mm s utisnutom oznakom „TZ30“ na jednoj strani.
The tablets are white, round, flat, bevelled, 8 mm in diameter and engraved with ‘TZ45’ on one side.
Tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 8 mm s utisnutom oznakom ‘TZ45’ na jednoj strani.
The tablets are white, round, flat, bevelled, 8 mm in diameter and engraved with ‘TZ45’ on one side.
Tablete su bijele, okrugle, ravne s ukošenim rubom, promjera 8 mm s utisnutom oznakom „TZ45“ na jednoj strani.
The tablets can be divided into equal halves.
Ove se tablete mogu prelomiti na dvije jednake polovice.
The tablets can be divided into equal halves.
Tableta se može razdijeliti na jednake polovice.
The tablets can be divided into equal halves.
Tablete se mogu podijeliti na jednake polovice.
The tablets can be divided into equal halves.
Tablete se mogu podijeliti u dvije jednake polovice.
The tablets can be taken with or without a meal at any time of the day.
Tablete se mogu uzimati neovisno o obroku, u bilo koje doba dana.
The tablets can be taken with or without food.
Mogu se uzimati s hranom ili bez nje.
The tablets cannot be split accurately as there is no break line.
Tablete se ne mogu točno prelomiti, jer nemaju razdjelnu crtu.
The tablets contain beef flavouring to improve palatability, and a study conducted in healthy dogs showed that they were voluntarily and fully consumed 75% of the time.
Tablete imaju aromu govedine kako bi im se poboljšao okus , a pokusi na zdravim psima su pokazali da 75 % pasa dobrovoljno u cijelosti pojede tabletu.
The tablets contain lactose monohydrate and therefore should not be administered to patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption.
Ove tablete sadrže laktozu hidrat i stoga se ne smiju primjenjivati u bolesnika s rijetkim nasljednim poremećajima nepodnošenja galaktoze, nedostatka Lapp laktaze ili malapsorpcijom glukoze- galaktoze.
The tablets have a 20 mm diameter and a thickness of 6.5 mm.
Tablete imaju promjer od 20 mm i debljine su 6,5 mm.
The tablets have ‘ESL 200’engraved on one side and are scored on the other side.
Tablete imaju utisnuto "ESL 200" na jednoj strani i razdjelnu crtu na drugoj strani.
The tablets have ‘ESL 400’engraved on one side and are scored on the other side.
Tablete imaju utisnuto "ESL 400" na jednoj strani i razdjelnu crtu na drugoj strani.
The tablets have ‘ESL 600’engraved on one side and are scored on the other side.
Tablete imaju utisnuto "ESL 600" na jednoj strani i razdjelnu crtu na drugoj strani.
The tablets have ‘ESL 800’engraved on one side and are scored on the other side.
Tablete imaju utisnuto "ESL 800" na jednoj strani i razdjelnui crtu na drugoj strani.
The tablets may be taken either with or without food and should be taken each day at about the same time.
Tablete se mogu uzimati sa ili bez hrane, se te uzimaju svaki dan, otprilike u isto vrijeme.
The tablets must always be taken after the patient has not eaten anything for at least six hours overnight and at least 30 minutes before the
Tablete se uvijek trebaju uzimati na prazan želudac, nakon što je bolesnik postio preko noći najmanje šest sati i
The tablets must be administered as a whole and should not be divided, broken or ground.
Tablete se moraju davati u cijelosti, ne smiju se lomiti ili mljeti.
The tablets must be swallowed whole.
Tablete se moraju progutati cijele.
The tablets must be swallowed with sufficient amounts of liquid.
Tablete se moraju progutati cijele s dovoljnom količinom tekućine.
The tablets must be taken whole and are not to be divided.
Tablete se moraju uzeti cijele i ne smiju se prepoloviti.
The tablets must not be split or cut.
Tablete se ne smiju lomiti niti rezati.
The tablets or the granules should be taken at 12-hour intervals with fat-containing foods, such as meals prepared with butter or oils or foods containing eggs, cheese, nuts, whole milk or meat.
Tablete ili granule treba uzimati u razmaku od 12 sati s hranom koja sadrži masti, poput obroka pripremljenih s maslacem ili uljima, odnosno s namirnicama koje sadrže jaja, sir, orašaste plodove, punomasno mlijeko ili meso.
The tablets should be administered either mixed with a small amount of food offered to the dog just prior to the main meal, or with the meal itself.
Tablete treba primjenjivati bilo u smjesi s malom količinom hrane ponuđenom psu neposredno prije glavnog obroka ili sa samim obrokom.
The tablets should be administered with a meal as a single daily dose, to increase the absorption, and at the same time each day preferably in the morning.
Tablete se uzimaju jednom dnevno, za vrijeme jela kako bi se povećala apsorpcija, svakog dana u isto vrijeme, poželjno ujutro.
The tablets should be administered with food, either mixed with a small amount of food offered to the dog just prior to the main meal, or with the meal itself.
Tablete treba primjenjivati bilo u smjesi s malom količinom hrane ponuđenom psu neposredno prije glavnog obroka ili sa samim obrokom.
The tablets should be kept in the original package until use in order to prevent children directly accessing the medicine.
Tablete treba čuvati u originalnom stanju sve do uporabe kako bi se spriječilo da djeca imaju izravan pristup VMP-u.
The tablets should be swallowed whole at the same time every day and should not be chewed or crushed.
Tablete je potrebno progutati cijele uvijek u isto doba dana i ne smije ih se žvakati ili drobiti.
The tablets should be swallowed whole with a drink of water.
Tabletu treba progutati cijelu s vodom.
The tablets should be swallowed whole with a full glass of water (180 to 240 ml) while the patient is standing or sitting in an upright position.
Tablete treba progutati cijele uz punu čašu obične vode (180 do 240 ml) dok bolesnik stoji ili sjedi u uspravnom položaju.
The tablets should be swallowed whole with a full glass of water (180 to 240 ml) while the patient is standing or sitting in an upright position.
Tablete treba progutati cijele uz punu čašu vode (180 do 240 ml) dok bolesnik stoji ili sjedi u uspravnom položaju.
The tablets should be swallowed whole with half a glass of water.
Tablete treba progutati cijele s pola čaše vode.
The tablets should be swallowed whole.
Reproduction is authorised provided the source is acknowledged.
The tablets should be taken by mouth and can be taken with or without food.
Tablete se uzimaju kroz usta i mogu se uzeti uz hranu ili bez nje.
The tablets should be taken orally with food in the morning and in the evening.
Tablete treba uzimati kroz usta s hranom ujutro i navečer.
The tablets should be taken whole and the suspension should be taken within 30 minutes of being prepared.
Tabletu treba uzeti cijelu, a suspenziju treba uzeti unutar 30 minuta od pripreme.
The tablets should be taken with food in the morning and in the evening (see section 5.2).
Tablete se trebaju uzimati uz hranu ujutro i navečer (vidjeti dio 5.2).
The tablets should not be broken or crushed, and
Tablete se ne smiju lomiti ili drobiti, te ih se ne smije sisati, žvakati ili gutati cijele.
The tablets should not be chewed, crushed or split due to anticipated changes in the pharmacokinetic profile
Tablete se ne smiju žvakati, drobiti niti lomiti zbog očekivanih promjena u farmakokinetičkom profilu.
The tablets work by preventing some of the fat you eat from being absorbed but you can still eat foods from all the main food groups.
Kapsule djeluju tako da sprječavaju apsorpciju dijela masti koji unesete hranom, no i dalje smijete jesti namirnice iz sve tri glavne skupine hrane.
The tablets work only in your digestive system to stop about a quarter of the fat in your meals from being absorbed.
Kapsule djeluju samo u probavnom sustavu tako što sprječavaju apsorpciju oko četvrtine masti unesene obrokom.
The tabulation below includes all adverse reactions in clinical trials where adverse events were considered related.
Tablični prikaz u nastavku uključuje sve nuspojave u kliničkim ispitivanjima gdje su štetni događaji smatrani povezanima.
The tabulation below includes all adverse reactions in clinical trials where adverse events were considered related..
Tablični prikaz u nastavku uključuje sve nuspojave u kliničkim ispitivanjima gdje su štetni događaji smatrani povezanima.
The Tafinlar doses should be about 12 hours apart.
Između doza Tafinlara mora biti
The tamper evident cap has been broken.
Zaštitni zatvarač s evidencijom otvaranja je slomljen.
The target dose of 28 mcg/day was administered in cycle 2 and subsequent cycles starting on day 1 of each cycle.
Ciljana doza od 28 µg/dan primijenjena je u drugom ciklusu i svim sljedećim ciklusima, počevši od 1. dana svakog ciklusa.
The target haemoglobin concentration in two studies was > 13 g/dl; in the remaining three studies it was 12-14 g/dl.
Ciljna koncentracija hemoglobina u 2 studije bila je >13 g/dl; u ostale 3 studije bila je 12-14 g/dl.
The target haemoglobin concentration in two studies was > 13 g/dl; in the remaining three studies it was 12-14 g/dl.
Ciljna koncentracija hemoglobina u dva ispitivanja bila je > 13 g/dl; u ostala tri ispitivanja bila je 12 – 14 g/dl.
The target haemoglobin concentration in two studies was > 13 g/dl; in the remaining three studies it was 12-14 g/dl.
Ciljna koncentracija hemoglobina u dva je ispitivanja bila >13 g/dl, a u preostala tri ispitivanja bila je 12 - 14 g/dl.
The target haemoglobin concentration in two studies was > 13 g/dl; in the remaining three studies it was 12-14 g/dl.
U dva ispitivanja ciljna koncentracija hemoglobina bila je >13 g/dl, a u preostala tri ispitivanja od 12 do 14 g/dl.
The target haemoglobin concentration in two studies was >13 g/dl; in the remaining three studies it was 12- 14 g/dl.
Ciljna koncentracija hemoglobina u dva je ispitivanja bila >13 g/dl, a u preostala tri ispitivanja bila je 12 - 14 g/dl.
The target haemoglobin concentration in two studies was >13 g/dl; in the remaining three studies it was 12- 14 g/dl.
Ciljna koncentracija hemoglobina u dva je ispitivanja bila >13 g/dl, a u preostala tri ispitivanja bila je između 12-14 g/dl.
The target haemoglobin concentration in two studies was >13 g/dl; in the remaining three studies it was 12-14 g/dl.
Ciljna koncentracija hemoglobina u dva je ispitivanja bila >13 g/dl, a u preostala tri ispitivanja bila je 12 - 14 g/dl.
The target therapeutic dose of BLINCYTO delivered does not change.
Ciljana dostavljena terapijska doza lijeka BLINCYTO se ne mijenja.
The target wound area of each patient was divided into two treatment areas of approximately the same size; the treatment allocation to the two halves of the wound (distal vs. proximal) was determined by randomization (in the burn trial, two similar wounds could be used).
Ciljno područje rane svakog bolesnika podijeljeno je na dva područja liječenja približno jednake veličine; raspodjela liječenja na dvije polovice rane (distalna naspram proksimalna) određena je randomizacijom (kod ispitivanja opeklina mogle su se upotrijebiti dvije slične rane).
The targeted maintenance dose is 1.3 gram/m2/day, in two divided doses, given every 12 hours.
Ciljna doza održavanja je 1,3 grama/m2/dan, podijeljena u dvije doze koje se uzimaju svakih 12 sati.
The targeted maintenance dose is 1.3 gram/m2/day.
Ciljna doza održavanja je 1,3 grama/m2/dan.
The targeted maintenance dose of 1.3 g/m2/day can be approximated according to the following table, which takes surface area as well as weight into consideration.
Ciljna doza održavanja od 1,3 g/m2/dan može se približno odrediti prema sljedećoj tablici koja u obzir uzima i površinu tijela i tjelesnu težinu.
The TAXOTERE 20 mg/0.5 ml vial contains a solution of docetaxel in polysorbate 80 at a concentration of 40 mg/ml.
TAXOTERE 20 mg/0,5 ml bočica sadržava otopinu docetaksela u polisorbatu 80, u koncentraciji od 40 mg/ml.
The TAXOTERE 20 mg/0.5 ml vial is a 7 ml clear glass vial with a green flip-off cap.
TAXOTERE 20 mg/0,5 ml bočica je prozirna staklena bočica od 7 ml sa zelenim "flip-off" zatvaračem.
The TAXOTERE 80 mg/2 ml vial contains a solution of docetaxel in polysorbate 80 at a concentration of 40 mg/ml.
TAXOTERE 80 mg/2 ml bočica sadržava otopinu docetaksela u polisorbatu 80, u koncentraciji od 40 mg/ml.
The TAXOTERE 80 mg/2 ml vial is a 15 ml clear glass vial with a red flip-off cap.
TAXOTERE 80 mg/2 ml bočica je prozirna staklena bočica od 15 ml s crvenim "flip-off" zatvaračem.
The TAXOTERE infusion solution should be used within 4 hours and should be aseptically administered as a 1-hour infusion under room temperature (below 25°C) and normal lighting conditions.
TAXOTERE infuzijska otopina mora se upotrijebiti unutar 4 sata nakon pripreme i to uz aseptičku primjenu jednosatnom intravenskom infuzijom pri sobnoj temperaturi (ispod 25°C) i uobičajenom osvjetljenju.
The Techne DB-3 Dri Block Heater is fully validated for use in the constitution of Myocet.
Grijač Techne DB-3 Dri Block je potpuno validiran za uporabu prilikom priprave Myoceta.
The technical data are given only for information and should not limit health-care providers’ choice.
Tehnički podaci dani su samo informativno i ne smiju ograničavati izbor zdravstvenim djelatnicima.